|
(b)(4) date sent to the fda: 11/9/2020 additional information: d4, h4, h6 a manufacturing record evaluation was performed for the finished device lot number ppbddt / xn8834h19, and no non-conformances related to the reported complaint condition were identified.Additional h3 investigation summary: it was reported needle rupture.Two pictures were received for evaluation.Upon visual inspection of pictures, two winding formers and a needle broken in two section near of the swage of product code 8834, lot # ppbddt could be observed.To avoid this kind of damage: grasp the needle in an area one-third (1/3) to one-half (1/2) of the distance from the attachment end to the point.As part of our quality process, the manufacturing records of this lot-serial number were reviewed, and the manufacturing standards were met prior to the release of this batch.No conclusion could be reached as on what caused the needle broke since device was not returned for analysis.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon inc, or its employees that the report constitutes an admission that the product, ethicon inc, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
|